欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Mouse Submaxillary gland androgen-regulated protein 2, isoform epsilon (Smr2) CSB-YP522054MO
CSB-EP522054MO
CSB-BP522054MO
CSB-MP522054MO
CSB-EP522054MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Submaxillary gland androgen-regulated protein 2, isoform delta (Smr2) CSB-YP522055MO
CSB-EP522055MO
CSB-BP522055MO
CSB-MP522055MO
CSB-EP522055MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Putative ribosomal RNA methyltransferase C4F10.03c (SPAC4F10.03c) CSB-YP522056SXV
CSB-EP522056SXV
CSB-BP522056SXV
CSB-MP522056SXV
CSB-EP522056SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Autophagy protein 13 (atg13), partial CSB-YP522057SXV
CSB-EP522057SXV
CSB-BP522057SXV
CSB-MP522057SXV
CSB-EP522057SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Kinetochore protein fta1 (fta1) CSB-YP522058SXV
CSB-EP522058SXV
CSB-BP522058SXV
CSB-MP522058SXV
CSB-EP522058SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C4F10.17 (SPAC4F10.17) CSB-YP522059SXV
CSB-EP522059SXV
CSB-BP522059SXV
CSB-MP522059SXV
CSB-EP522059SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eukaryotic translation initiation factor 2 subunit gamma CSB-YP522060FKN
CSB-EP522060FKN
CSB-BP522060FKN
CSB-MP522060FKN
CSB-EP522060FKN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Uncharacterized gene A1 protein (A1) CSB-YP522061AZG
CSB-EP522061AZG
CSB-BP522061AZG
CSB-MP522061AZG
CSB-EP522061AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 DNA polymerase catalytic subunit (9), partial CSB-YP522062AZG
CSB-EP522062AZG
CSB-BP522062AZG
CSB-MP522062AZG
CSB-EP522062AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Gene 18 protein (18) CSB-YP522063AZG
CSB-EP522063AZG
CSB-BP522063AZG
CSB-MP522063AZG
CSB-EP522063AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Envelope glycoprotein H (gH), partial CSB-YP522064AZG1
CSB-EP522064AZG1
CSB-BP522064AZG1
CSB-MP522064AZG1
CSB-EP522064AZG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Uncharacterized gene 27 protein (27), partial CSB-YP522065AZG1
CSB-EP522065AZG1
CSB-BP522065AZG1
CSB-MP522065AZG1
CSB-EP522065AZG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Virion-packaging protein 32 (32) CSB-YP522066AZG
CSB-EP522066AZG
CSB-BP522066AZG
CSB-MP522066AZG
CSB-EP522066AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Putative tyrosine kinase 36 (36) CSB-YP522067AZG
CSB-EP522067AZG
CSB-BP522067AZG
CSB-MP522067AZG
CSB-EP522067AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Gene 42 protein (42) CSB-YP522068AZG
CSB-EP522068AZG
CSB-BP522068AZG
CSB-MP522068AZG
CSB-EP522068AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Uncharacterized gene 48 protein (48) CSB-YP522069AZG
CSB-EP522069AZG
CSB-BP522069AZG
CSB-MP522069AZG
CSB-EP522069AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Uncharacterized gene 52 protein (52) CSB-YP522070AZG
CSB-EP522070AZG
CSB-BP522070AZG
CSB-MP522070AZG
CSB-EP522070AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Gene 58 protein (58), partial CSB-YP522071AZG
CSB-EP522071AZG
CSB-BP522071AZG
CSB-MP522071AZG
CSB-EP522071AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Capsid protein VP65 (65) CSB-YP522072AZG
CSB-EP522072AZG
CSB-BP522072AZG
CSB-MP522072AZG
CSB-EP522072AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Virion egress protein 69 (69), partial CSB-YP522073AZG1
CSB-EP522073AZG1
CSB-BP522073AZG1
CSB-MP522073AZG1
CSB-EP522073AZG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×